Conference Material
|
Slide Presentation
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
Yatskevich N,
Hurevich H,
Solodovnikova V,
Garsevanidze E,
Lachenal N,
Alvarez JL,
Sitali N,
Sinha A,
Skrahina A
View HTML
View PDF
Share
Download
Download
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
No abstract available
Countries
Belarus
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
Languages
English
DOI
10.57740/3sk2-bf43
Published Date
07 Jun 2023
Conference
MSF Scientific Day International 2023
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus | Conference Material / Slide Presentation | MSF Science Portal
